North America leads the Gynecology Electrodes market, capturing 40% of global revenue in 2023. Market dominance stems from advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust R&D investments. Stringent regulatory frameworks and reimbursement policies also drive innovation. Europe follows closely with 25% share, fueled by rising gynecological disorder prevalence and a mature medical device ecosystem. Asia Pacific is the fastest-growing region, expanding at a CAGR of 12% through 2030, driven by urbanization, rising healthcare access, and government initiatives to modernize facilities. Latin America and the Middle East & Africa, with 15% and 10% shares respectively, benefit from improving healthcare policies and digital health integration, though infrastructure gaps remain a challenge. The regional forecast highlights Asia Pacificโs potential to surpass Europe by 2030, as demographic shifts and targeted investments accelerate adoption.